NEXPOVIO

This brand name is authorized in Estonia, Croatia, Ireland, Italy, Lithuania, Poland

Active ingredients

The drug NEXPOVIO contains one active pharmaceutical ingredient (API):

1 Selinexor UNII 31TZ62FO8F - SELINEXOR

Selinexor is a nuclear export inhibitor. In nonclinical studies, selinexor reversibly inhibits nuclear export of tumor suppressor proteins (TSPs), growth regulators, and mRNAs of oncogenic proteins by blocking exportin 1 (XPO1). Read about Selinexor

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01XX66		L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents
Discover more medicines within L01XX66

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1846032, 1846043, 1846054, 1846065
Country: IT	Agenzia del Farmaco	Identifier(s): 049430010, 049430022, 049430034, 049430046, 049430059
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1092320, 1092321, 1092322, 1092323
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100450150